Chennai Meenakshi Multispeciality Hospital (BOM:523489) 3-Year RORE % : 24.62% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:523489 Chennai Meenakshi Multispeciality Hospital Ltd BOM:523489
62 GF Score
Price ₹38.19
GF Value ₹36.08
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Chennai Meenakshi Multispeciality Hospital 3-Year RORE %?

Chennai Meenakshi Multispeciality Hospital BOM:523489 -2.03% 62 3-Year RORE % is 24.62 as of Mar. 2026. GuruFocus rates BOM:523489 with a GF Score™ of 62/100 and a GF Value™ of ₹36.08 (Fairly Valued). The stock has 2 warning signs investors should review. Among 597 Healthcare Providers & Services companies, Chennai Meenakshi Multispeciality Hospital ranks better than 73.2% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % for the quarter that ended in Mar. 2026 was 24.62%.

The industry rank for Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % or its related term are showing as below:

BOM:523489's 3-Year RORE % is ranked better than
73.2% of 597 companies
in the Healthcare Providers & Services industry
Industry Median: 1.27 vs BOM:523489: 24.62

Chennai Meenakshi Multispeciality Hospital  (BOM:523489) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Chennai Meenakshi Multispeciality Hospital 3-Year RORE % Related Terms


Chennai Meenakshi Multispeciality Hospital 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chennai Meenakshi Multispeciality Hospital 3-Year RORE % Chart

Chennai Meenakshi Multispeciality Hospital Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.86 59.09 -99.16 249.59 24.62

Chennai Meenakshi Multispeciality Hospital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 249.59 154.22 90.64 40.90 24.62

BOM:523489 vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Chennai Meenakshi Multispeciality Hospital's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chennai Meenakshi Multispeciality Hospital 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % falls into.


BOM:523489
62GF Score
Chennai Meenakshi Multispeciality Hospital Ltd BOM:523489
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chennai Meenakshi Multispeciality Hospital 3-Year RORE % Calculation

Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -1.54--0.57 )/( -3.94-0 )
=-0.97/-3.94
=24.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 24.62 mean?
Chennai Meenakshi Multispeciality Hospital (BOM:523489) has a 3-Year RORE % of 24.62 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Chennai Meenakshi Multispeciality Hospital and its competitors. According to the industry distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #160 out of 597 companies in the Healthcare Providers & Services industry, placing it in the top 26.8%.
Is Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % too high?
Chennai Meenakshi Multispeciality Hospital's current 3-Year RORE % is 24.62. The Healthcare Providers & Services industry median 3-Year RORE % is 1.27. Chennai Meenakshi Multispeciality Hospital's value of 24.62 is 1838.6% above this industry median. Based on the distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #160 out of 597 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Chennai Meenakshi Multispeciality Hospital has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chennai Meenakshi Multispeciality Hospital's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #160 out of 597 companies for 3-Year RORE %. This puts Chennai Meenakshi Multispeciality Hospital in the upper half of its industry. The industry median 3-Year RORE % is 1.27. Chennai Meenakshi Multispeciality Hospital's value of 24.62 is 1838.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 1.27, based on 597 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chennai Meenakshi Multispeciality Hospital's current 3-Year RORE % of 24.62 is 1838.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Chennai Meenakshi Multispeciality Hospital and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chennai Meenakshi Multispeciality Hospital's current 3-Year RORE % is 24.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chennai Meenakshi Multispeciality Hospital stock overvalued right now?
Based on GuruFocus' analysis, Chennai Meenakshi Multispeciality Hospital (BOM:523489) is currently considered Fairly Valued. The stock's GF Value™ is ₹36.08, compared to a current price of ₹38.19 — trading 5.8% above its estimated fair value. The current 3-Year RORE % is 24.62 and 1838.6% above the Healthcare Providers & Services industry median of 1.27. Chennai Meenakshi Multispeciality Hospital's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Chennai Meenakshi Multispeciality Hospital (BOM:523489), the current 3-Year RORE % is 24.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chennai Meenakshi Multispeciality Hospital (BOM:523489) Overvalued in 2026?

Based on GuruFocus' analysis, Chennai Meenakshi Multispeciality Hospital stock appears to be overvalued. The current stock price of ₹38.19 is trading 5.8% above its estimated GF Value™ of ₹36.08. GuruFocus considers Chennai Meenakshi Multispeciality Hospital to be Fairly Valued.

Key valuation signals for BOM:523489:

  • 3-Year RORE %: 24.62
  • GF Value™: ₹36.08 vs. price of ₹38.19 (5.8% above fair value)
  • GF Score™: 62/100 with 2 warning signs
  • Industry Position: 1838.6% above the Healthcare Providers & Services median (#160 of 597)

No single metric tells the full story. See the BOM:523489 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chennai Meenakshi Multispeciality Hospital Business Description

Address Luz Church Road, New No. 70, Old No. 149, Mylapore, Chennai, TN, IND, 600004
Website http://cmmh.in
Chennai Meenakshi Multispeciality Hospital Ltd is an India-based company engaged in hospital activities. It provides healthcare for the society in various branches of medicine, such as General Surgery, General Medicine, Pediatrics, Neurology, Cardiology, ENT, Ophthalmology, Radiology, Pathology, Gastroenterology, Urology, Thoracic Surgery, Plastic Surgery, Orthopedics, and other allied specialties.
62GF Score

Get the complete analysis for BOM:523489

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.19
Price
₹36.08
GF Value